About Seegene Technologies
Seegene Technologies is a company based in Seoul (South Korea) founded in 2000 was acquired by Pfizer in March 2023. The company has 862 employees as of December 31, 2024. Seegene Technologies has completed 1 acquisition, including BREX. Seegene Technologies operates in a competitive market with competitors including Avidity Biosciences, Prenetics, Univercells, Sutro Biopharma and OpGen, among others.
- Headquarter Seoul, South Korea
- Employees 862 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Seegene, Inc.
-
Annual Revenue
$280.86 M (USD)12.76as on Dec 31, 2024
-
Net Profit
-$13.79 M (USD)-3139.83as on Dec 31, 2024
-
EBITDA
$37.1 M (USD)53.45as on Dec 31, 2024
-
Latest Funding Round
$1.59 M (USD), Grant
Dec 01, 2019
-
Investors
Pfizer
& 1 more
-
Employee Count
862
as on Dec 31, 2024
- Investments & Acquisitions
-
Acquired by
Pfizer
(Mar 13, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Seegene Technologies
Seegene Technologies is a publicly listed company on the KRX with ticker symbol 096530 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Seegene Technologies
Unlock access to complete
Funding Insights of Seegene Technologies
Investors in Seegene Technologies
Seegene Technologies has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Pfizer and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Pharmaceutical products for treating multiple diseases are provided.
|
Locked | Locked | Locked |
Investor details for Seegene Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Seegene Technologies
Seegene Technologies has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include BREX.
Investment portfolio details for Seegene Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
UI/UX consulting services are provided in Seoul, South Korea.
|
Locked | Locked | 2019 | Locked |
Complete acquisition details for Seegene Technologies
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Seegene Technologies
Detailed financials for Seegene Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Seegene Technologies Comparisons
Peer comparison for Seegene Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Seegene Technologies
Seegene Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Prenetics, Univercells, Sutro Biopharma and OpGen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
Detailed competitors of Seegene Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Seegene Technologies
Complete news archive for Seegene Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Seegene Technologies
Seegene Technologies was founded in 2000 and raised its 1st funding round 19 years after it was founded.
Seegene Technologies is headquartered in Seoul, South Korea.
Jong Yoon Chun is the current CEO of Seegene Technologies.
As of Dec 31, 2024, the latest employee count at Seegene Technologies is 862.
Annual revenue of Seegene Technologies is $280.86M as on Dec 31, 2024.
Seegene Technologies was founded in 2000 and is based in Seoul, South Korea. Operations focus on the molecular diagnostics sector, where in vitro diagnostic (IVD) tests are created to identify disease causes through nucleic acid analysis, including DNA and RNA. Reagents and kits are produced for conditions such as respiratory infections, gastrointestinal disorders, sexually transmitted diseases, human papillomavirus, tuberculosis, sepsis, and meningitis.
Seegene Technologies's top competitors include Sutro Biopharma, Avidity Biosciences and Prenetics.
Yes, Seegene Technologies is publicly traded on KRX under the ticker symbol 096530.
Seegene Technologies has made 1 acquisition, including BREX.
The ticker symbol of Seegene Technologies is 096530 on KRX.